These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21150394)

  • 21. Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis.
    Zaidat OO; Castonguay AC; Fitzsimmons BF; Woodward BK; Wang Z; Killer-Oberpfalzer M; Wakhloo A; Gupta R; Kirshner H; Eliasziw M; Thomas Megerian J; Shetty S; Yoklavich Guilhermier M; Barnwell S; Smith WS; Gress DR;
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1131-9. PubMed ID: 23261207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research priorities for intracranial atherosclerotic diseases.
    Qureshi AI; Taylor RA
    J Neuroimaging; 2009 Oct; 19 Suppl 1():39S-42S. PubMed ID: 19807858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of magnetic resonance angiography to predict long-term outcomes of ischemic stroke patients with concurrent stenoses in Hong Kong.
    Man BL; Fu YP; Chan YY; Lam W; Hui CF; Leung WH; Wong KS
    Cerebrovasc Dis; 2009; 28(2):112-8. PubMed ID: 19506369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical management trumps stenting for intracranial arterial stenosis.
    Rosenberg K
    Am J Nurs; 2011 Dec; 111(12):16. PubMed ID: 22112875
    [No Abstract]   [Full Text] [Related]  

  • 25. Significance of good collateral compensation in symptomatic intracranial atherosclerosis.
    Lau AY; Wong EH; Wong A; Mok VC; Leung TW; Wong KS
    Cerebrovasc Dis; 2012; 33(6):517-24. PubMed ID: 22538868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion-weighted imaging showing 'pearls' predicts large-vessel disease as stroke etiology.
    Turtzo LC; Gottesman RF; Llinas RH
    Cerebrovasc Dis; 2009; 28(1):49-54. PubMed ID: 19468215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracranial atherosclerotic disease: common, dangerous, and treatable.
    Hanel RA; Levy EL; Guterman LR; Hopkins LN
    Clin Neurosurg; 2005; 52():68-75. PubMed ID: 16626056
    [No Abstract]   [Full Text] [Related]  

  • 28. Posterior cerebral artery stenosis.
    Pessin MS; Kwan ES; DeWitt LD; Hedges TR; Gale D; Caplan LR
    Ann Neurol; 1987 Jan; 21(1):85-9. PubMed ID: 3827217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asymptomatic Intracranial Atherosclerotic Stenosis: The Risk Above the Carotids.
    Turan TN; Kicielinski KP
    J Am Coll Cardiol; 2021 Aug; 78(6):572-574. PubMed ID: 34353534
    [No Abstract]   [Full Text] [Related]  

  • 30. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients.
    Rohde S; Seckinger J; Hähnel S; Ringleb PA; Bendszus M; Hartmann M
    Int J Stroke; 2013 Feb; 8(2):87-94. PubMed ID: 22296983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis.
    Ovbiagele B; Lynn MJ; Saver JL; Chimowitz MI;
    Cerebrovasc Dis; 2007; 24(2-3):283-8. PubMed ID: 17646693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracranial atherosclerotic disease: medical, biomechanical, imaging, and flow dynamics perspective.
    Suri MF; Divani AA; Hoffmann KR; Qureshi AI
    J Neuroimaging; 2009 Apr; 19(2):150-7. PubMed ID: 19021837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis.
    Qureshi AI; Kirmani JF; Hussein HM; Harris-Lane P; Divani AA; Suri MF; Janjua N; Alkawi A
    Neurosurgery; 2006 Nov; 59(5):1044-51; discussion 1051. PubMed ID: 17143239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombolysis and hyperacute reperfusion therapy for stroke in renal patients.
    Hirano T
    Contrib Nephrol; 2013; 179():110-8. PubMed ID: 23652454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of cerebral artery risk evaluation before off-pump coronary artery bypass grafting to avoid perioperative stroke.
    Doi K; Yaku H
    Eur J Cardiothorac Surg; 2010 Nov; 38(5):568-72. PubMed ID: 20399676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carotid atherosclerotic disease and cognitive function: mechanisms identifying new therapeutic targets.
    Balucani C; Silvestrini M
    Int J Stroke; 2011 Aug; 6(4):368-9. PubMed ID: 21745348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of asymptomatic intracranial arterial stenosis.
    Taylor RA; Kasner SE
    J Neuroimaging; 2009 Oct; 19 Suppl 1():17S-9S. PubMed ID: 19807852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of albumin levels with the risk of intracranial atherosclerosis.
    Lin X; Ke F; Chen M
    BMC Neurol; 2023 May; 23(1):198. PubMed ID: 37210474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracranial atherosclerotic disease: an update.
    Qureshi AI; Feldmann E; Gomez CR; Johnston SC; Kasner SE; Quick DC; Rasmussen PA; Suri MF; Taylor RA; Zaidat OO
    Ann Neurol; 2009 Dec; 66(6):730-8. PubMed ID: 20035502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. My patient has intracranial stenosis, does he need an intracerebral stent? Results of the SAMMPRIS study.
    Wadiwala MF; Kamal AK
    J Pak Med Assoc; 2013 May; 63(5):654-5. PubMed ID: 23758002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.